arrow
N

Nelly Ciobanu

phthisiopneumology institute
H指数:9
被引数:390

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

High rates of acquired resistance to fluoroquinolones, bedaquiline and linezolid in patients failing treatment against drug-resistant tuberculosis in the Republic of Moldova

摩尔多瓦共和国耐药结核病患者对氟喹诺酮类药物、巴结芬净和利奈唑胺获得性耐药率较高。

2025-09-110
PRE
Diagnostic accuracy and predictive value of the QuantiFERON-TB gold plus assay for tuberculosis in immunocompromised individuals: a prospective TBnet study

结核病在免疫抑制个体中QuantiFERON-TB gold plus检测的诊疗准确性与预测价值:一项前瞻性TBnet研究

2025-08-060
PREAI
Sex differences in risk factors for unsuccessful tuberculosis treatment outcomes in Eastern Europe from 2020 to 2022: a multi-country retrospective cohort study

2020年至2022年东欧国家结核病治疗失败风险因素的性别差异:一项多国回顾性队列研究

2025-06-250
PRE
Multidrug-resistant tuberculosis and treatment outcomes in Kazakhstan, Moldova, Ukraine, Georgia, and Kyrgyzstan
2024-10-300
PRE
Clinical Evaluation of the XDR-LFC Assay for the Molecular Detection of Isoniazid, Rifampin, Fluoroquinolone, Kanamycin, Capreomycin, and Amikacin Drug Resistance in a Prospective Cohort
2023-03-233
OA
Phylogeography and transmission of M. tuberculosis in Moldova: A prospective genomic analysis
2022-02-2220
OAAI
Detection of isoniazid, fluoroquinolone, ethionamide, amikacin, kanamycin, and capreomycin resistance by the Xpert MTB/XDR assay: a cross-sectional multicentre diagnostic accuracy study
2022-02-0157
OAAI